Acquiring Company
Lantheus Holdings
Acquired Company
Evergreen Theragnostics
BedfordSummitBiotechnologyHealth CareTherapeuticsManufacturingBiotechnologyHealth CareMedical DeviceDescription
Lantheus Holdings, Inc. has completed the acquisition of Evergreen Theragnostics. This move is part of Lantheus' strategy to enhance its portfolio in innovative PET radiodiagnostics. The acquisition aligns with the company's focus on developing cutting-edge diagnostic solutions. Significant investments were also directed towards the acquisition of Life Molecular Imaging.
Who to call at Lantheus Holdings, and when
When Lantheus Holdings changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Lantheus Holdings raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lantheus Holdings, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lantheus Holdings makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Evergreen Theragnostics?
Evergreen Theragnostics was acquired by Lantheus Holdings, based in Bedford. The deal was reported on February 27, 2026. Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Lantheus Holdings is publicly traded (LNTH) and operates in Biotechnology.
When did Lantheus Holdings acquire Evergreen Theragnostics?
Lantheus Holdings's acquisition of Evergreen Theragnostics was reported on February 27, 2026. Lantheus Holdings, Inc. has completed the acquisition of Evergreen Theragnostics. This move is part of Lantheus' strategy to enhance its portfolio in innovative PET radiodiagnostics. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Evergreen Theragnostics do?
Evergreen Theragnostics is focused on improving the available options for cancer patients using radiopharmaceuticals. The company is engaged in three core areas: CDMO, Products, and Drug Discovery. It is privately held, operating in Manufacturing, and is based in Summit.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.